Table 1.

Patient (N = 15) and tumor characteristics

Age (years; median [range])	72 [63–77]
Prognostic risk group a : (no. of patients)
1 – Low risk	1 (7%)
2 – Intermediate risk	5 (33%)
3 – High risk	9 (60%)

^a Low risk: no risk factors: PSA <10 ng/ml; Gleason score <7; cT stage <2b; Intermediate risk: PSA 10–20 ng/ml and/or Gleason score = 7 or cT stage = 2b/c; High risk: PSA >20 ng/ml or Gleason score >7 or cT stage >2b/c